CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension [Phase 3]

Phase 3 trial results for GMRx2 in hypertension show its efficacy and safety when compared with dual drug regimens. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: George Medicines PTY Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-06-03